Skip to main content
Premium Trial:

Request an Annual Quote

Deloitte Consulting Buys Analytics Firm Recombinant Data

NEW YORK (GenomeWeb News) – Deloitte Consulting late on Tuesday announced it has acquired Recombinant Data for an undisclosed amount.

Based in Newton, Mass., Recombinant Data provides healthcare IT solutions and research data management and analytics. Its products and services, Deloitte Consulting said, are used to advance personalized medicine, translational research — including genomics, phenomics, and proteomics — and healthcare performance management.

Its services allow academic medical centers, federal agencies, and life science firms to "conduct translational research and analyze phenomic, genomic, and biobanking data in pursing personalized and evidence-based medicine," Deloitte Consulting said. "These solutions can help clients unlock the underlying power of digital data."

The deal, Recombinant Data added, will accelerate its product development, sales, and staffing, while expanding Deloitte Consulting's footprint in Boston.

The business will be incorporated within Deloitte Consulting Innovation under the name Recombinant by Deloitte. Recombinant Data, Deloitte Consulting said, has seen "significant" year-over-year growth since its founding in 2005.

"Joining forces with Recombinant represents a bold move around innovation that will open new horizons for Deloitte in the life sciences and healthcare sectors,” Andrew Vaz, principal and chief innovation officer of Deloitte Consulting, said in a statement. "It will extend the Deloitte brand into hybrid business models in which world-class services are combined with advanced intellectual property assets."

Deloitte Consulting is a subsidiary of Deloitte.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.